A landmark study in Lancet Diabetes & Endocrinology identified a T1D subtype in Sub-Saharan African youth and Black Americans lacking islet autoantibodies. This insulin-deficient form isn't autoimmune, urging revised diagnostic, prevention, and treatment strategies.
Did you know? A randomized crossover trial published in August 2025 demonstrated that a DASH diet modified for type 2 diabetes (DASH4D) significantly improved glycemic control. Adults with T2D on the DASH4D regimen experienced greater reductions in mean CGM glucose and increased time in the target range compared to standard U.S. dietary patterns. Improvements were most pronounced in participants with elevated baseline A1C.
Could evidence-based dietary frameworks like DASH4D enhance existing treatment plans for patients with complex metabolic profiles?

Could evidence-based dietary frameworks like DASH4D enhance existing treatment plans for patients with complex metabolic profiles?
Lipoprotein(a) and Effects of Diet: Time for Reassessment - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/40431454/
Dietary modification is a critical tool in the prevention of cardiovascular disease (CVD). While the role of saturated fat (SFA) intake is well established in affecting LDL cholesterol concentrations, diet...
This review explores how diet, particularly saturated fat, sugar, and ketogenic intake, influences lipoprotein(a) concentrations, highlighting genetic interactions, cardiovascular risk implications, and unmet research needs in dietary modulation.

